Cargando...
Rapid progression of disease from immunotherapy following targeted therapy: insights into treatment management and sequence
With emerging promising therapeutic regimens in non-small cell lung cancer (NSCLC), the standard-of-care treatments for a variety of histologic and mutated subgroups in NSCLC has been regularly shifting in response to landmark clinical trials. However, with the availability of a range of therapeutic...
Guardado en:
| Publicado en: | J Thorac Dis |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7578509/ https://ncbi.nlm.nih.gov/pubmed/33145086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.08.14 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|